Standout Papers

Dabigatran versus Warfarin in Patients with Atrial Fibrillati... 2000 2026 2008 2017 7.8k
  1. Dabigatran versus Warfarin in Patients with Atrial Fibrillation (2009)
    Stuart J. Connolly, Michael D. Ezekowitz et al. New England Journal of Medicine
  2. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes (2009)
    Lars Wallentin, Richard C. Becker et al. New England Journal of Medicine
  3. Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease (2000)
    Bertil Lindahl, Henrik Toss et al. New England Journal of Medicine
  4. Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden (2007)
    Bo Lagerqvist, Stefan James et al. New England Journal of Medicine
  5. Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation (2011)
    John W. Eikelboom, Lars Wallentin et al. Circulation
  6. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial (2010)
    Lars Wallentin, Salim Yusuf et al. The Lancet
  7. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials (2017)
    Francesco Costa, David van Klaveren et al. The Lancet
  8. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials (2002)
    Eric Boersma, Robert A. Harrington et al. The Lancet
  9. The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients (2013)
    Paul Reilly, Thorsten Lehr et al. Journal of the American College of Cardiology
  10. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial (2010)
    Lars Wallentin, Stefan James et al. The Lancet
  11. The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) (2010)
    Tomas Jernberg, Mona From Attebring et al. Heart
  12. Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes (2005)
    Shamir R. Mehta, Christopher P. Cannon et al. JAMA
  13. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study (2010)
    Christopher P. Cannon, Robert A. Harrington et al. The Lancet
  14. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial (2012)
    Stefan H. Hohnloser, Ziad Hijazi et al. European Heart Journal
  15. Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease (2016)
    Kai C. Wollert, Tibor Kempf et al. Clinical Chemistry
  16. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study (2016)
    Ziad Hijazi, Jonas Oldgren et al. The Lancet
  17. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation (2016)
    Ziad Hijazi, Johan Lindbäck et al. European Heart Journal
  18. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014 (2017)
    Karolina Szummer, Lars Wallentin et al. European Heart Journal

Immediate Impact

1 from Science/Nature 113 standout
Sub-graph 1 of 17

Citing Papers

A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
2019 Standout
Genome-wide association studies of brain imaging phenotypes in UK Biobank
2018 StandoutNature
22 intermediate papers

Works of Lars Wallentin being referenced

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome
2016
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
and 44 more

Author Peers

Author Last Decade Papers Cites
Lars Wallentin 47953 13944 7240 14817 733 57.5k
Christopher B. Granger 48225 13453 9696 7147 833 62.0k
Elliott M. Antman 46958 16447 10589 9335 515 57.8k
Keith A.A. Fox 46242 15084 10760 11912 808 57.9k
Harvey D. White 43840 21177 13505 5684 705 56.2k
John W. Eikelboom 34233 9081 1789 18050 653 46.1k
Eugene Braunwald 49596 29906 11807 7900 687 75.0k
Mary Cushman 21673 10339 2525 12909 755 55.3k
Philippe Gabríel Steg 54884 29325 9926 9318 1.1k 74.8k
Eugene Braunwald 41820 18050 12184 4435 444 56.1k
David A. Morrow 28608 12434 8970 2586 579 42.3k

All Works

Loading papers...

Rankless by CCL
2026